Analyst firms · Needham · HOLX
Needham HOLX price target and rating history
Hologic Inc. (HOLX) · Health Care
Needham rates Hologic Inc. (HOLX) Hold with a $90 price target, as of its latest action on May 27, 2025. It has published 4 rating actions on HOLX since July 2023, including 1 upgrade and 1 downgrade.
- Current rating
- Hold
- Price target
- $90
- Median target, all firms
- Too few
- Actions on HOLX
- 4
Needham price target on HOLX
Every Needham rating on HOLX
- May 27, 2025ReiterateNeedham reiterates Hold
- Feb 3, 2025DowngradeNeedham downgrades to Hold from Buy
- Dec 10, 2024
- Jul 14, 2023
How other firms rate HOLX
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Argus Research | Hold | Jan 12, 2026 | |
| Evercore ISI | In-line | $78 | Jan 5, 2026 |
| BNP Paribas Exane | Neutral | $79 | Nov 21, 2025 |
Questions about Needham and HOLX
- What is Needham's price target for HOLX?
- Needham's latest stated price target for Hologic Inc. (HOLX) is $90, from its action on Dec 10, 2024.
- What is Needham's rating on HOLX?
- Needham rates HOLX Hold, a neutral rating, as of May 27, 2025.
- When did Needham last change its view on HOLX?
- On May 27, 2025, Needham reiterates Hold.
More HOLX rating histories
All Needham ratingsHOLX news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.